Docetaxel: response in patients who have received at least two prior chemotherapy regimes for metastatic breast cancer
- 31 May 1998
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (6) , 816-819
- https://doi.org/10.1016/s0959-8049(97)10113-7
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTCBritish Journal of Cancer, 1996
- A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancerBritish Journal of Cancer, 1996
- A phase II trial with Docetaxel (Taxotere™) in second line treatment with chemotherapy for advanced breast cancerAnnals of Oncology, 1994
- Systemic Therapy of Advanced Breast CancerDrugs, 1992
- Reporting results of cancer treatmentCancer, 1981